Fig. 4From: Two cases of unresectable hepatocellular carcinoma treated via atezolizumab and bevacizumab combination therapyTime line of chemotherapy and changes in levels of DCP and AFP in case 2. The circle numbers are administration courses. AFP alph-fetoprotein, DCP des-gamma carboxyprothrombinBack to article page